Thu Sep 26 13:31:40 UTC 2024: ## GENinCode Plc Shares Plunge 7.7% on Thursday
**London, UK – September 26, 2024** – GENinCode Plc (LON: GENI), a leading provider of clinical genetic tests in the UK and internationally, saw its share price drop significantly on Thursday, closing at GBX 6 ($0.08), a 7.7% decline from the previous day’s close. The stock traded as low as GBX 6 ($0.08) during the session, with only 117,043 shares changing hands, representing a 48% decrease from the average trading volume.
The company, which develops and commercializes predictive genetic tests to assess health risks, has a market cap of £10.62 million. Despite the recent dip, GENinCode’s stock has a fifty-day moving average of GBX 6.58 and a two-hundred day moving average of GBX 6.83, indicating some stability in its performance.
The company’s focus on preventative care and treatment strategies through its genetic analysis technology continues to attract investor interest, but the reasons behind the significant decline in share price on Thursday remain unclear.
**Disclaimer:** This is a news article summarizing information provided by MarketBeat News. It does not constitute financial advice, and readers are encouraged to conduct their own research before making any investment decisions.
First Piper 